The Latest Breaking News from Medicare

A rough earnings report raised troubling questions about UHG’s future, and so did the resignation of CEO Andrew Witty.

Sen. Rick Scott accused Americans of defrauding Medicaid, despite one of his previous companies being found guilty of doing just that, leading to backlash.

President Donald Trump said his executive order on drug prices would lower some prices in half or more. But the details are scant.

On election night, a triumphant Anthony Albanese took to the stage brandishing a Medicare card as a symbol of the nation’s commitment to public healthcare.

Volatility is back in a normal range, and the trend for the main equity indexes remains positive despite specific and general headwinds.

Justice department investigation into health insurance giant reported as company’s CEO says he will retire

UnitedHealth said it was not notified about the “supposed criminal investigation reported.”

Republicans in Congress intend to cut about US$880 billion in federal health care spending.

President Trump recently signed a wide-ranging executive order urging Congress to amend a crucial provision of a Biden-era law governing Medicare drug price negotiations, with the administration’s aim being to lower prices without kneecapping pharmaceutical industry investments in the research and development of innovative new drugs. The executive order marks…

President has directed Robert Kennedy to send price targets to industry, with slimming drugs thought to be included

Elon Musk promised $2 trillion in cuts but delivered only a tiny portion of that total. We asked seven policy experts to explain what he got wrong.